The OneMedNet collaborates with Palantir to advance healthcare AI and data analytics to provide real-time data and insights of the regulatory-compliant data across research networks worldwide.

OneMedNet Corporation has matched forces with Palantir Technologies to revamp the healthcare analytics marketplace using AI and real-world data (RWD). With the help of the Palantir Artificial Intelligence Platform to drive their iRWDtm, OneMedNet will provide life sciences, medical device, and research organizations a point of access into regulatory quality clinical data and cutting-edge data analytics.

The five-year partnership will unify Palantir with OneMedNet's expansive network with over 5 billion administrative bills and 131 million clinical examinations at 1,750-plus provider locations in oncology, cardiology, and rare diseases. Such integration will boost the ability to do data analytics efficiently in order to arrive at faster knowledge, better accuracy and compliant regulation of health research.

High-quality, regulatory-compliant data has been made possible at exceptional speed through the AIP of Palantir, as Aaron Green, the CEO of OneMedNet, puts it. It is the force that drives clinical research breakthroughs and AI in healthcare. The system facilitates quicker information searches, a dialogue-driven search engine with AI, workflow automation, and the anonymity of personal patient data to ensure compliance with healthcare requirements.

Through the use of Palantir, OneMedNet will be in a position to reach more people in the market, develop regulatory-grade cohorts of data, and streamline clinical trials, in addition to developing a scalable data analytic infrastructure. This project positions OneMedNet as a leader in AI-based healthcare by introducing innovative applications that enhance medical research and reduce patient risks.